Aristotle Capital Boston’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $8.76M | Buy |
|
|||||
|
2023
Q2 | $9.85M | Buy |
|
|||||
|
2023
Q1 | $15.4M | Buy |
|
|||||
|
2022
Q4 | $16.5M | Sell |
|
|||||
|
2022
Q3 | $20.6M | Sell |
|
|||||
|
2022
Q2 | $16.8M | Buy |
|
|||||
|
2022
Q1 | $28.3M | Buy |
|
|||||
|
2021
Q4 | $33.3M | Sell |
|
|||||
|
2021
Q3 | $34.6M | Buy |
|
|||||
|
2021
Q2 | $27.5M | Sell |
|
|||||
|
2021
Q1 | $30.7M | Buy |
|
|||||
|
2020
Q4 | $31M | Buy |
|
|||||
|
2020
Q3 | $17.2M | Buy |
|
|||||
|
2020
Q2 | $11M | Buy |
|